Burkitt Lymphoma Outcomes Following Implementation of Tanzania National Treatment Guidelines
Publication
, Conference
Gisiri, M; Joo, E; Penny, C; Horwitz, E; Makarushka, C; Vasudevan, L; Schroeder, K
Published in: PEDIATRIC BLOOD & CANCER
2021
Duke Scholars
Published In
PEDIATRIC BLOOD & CANCER
EISSN
1545-5017
ISSN
1545-5009
Publication Date
2021
Volume
68
Start / End Page
S79 / S80
Related Subject Headings
- Oncology & Carcinogenesis
- 3213 Paediatrics
- 3211 Oncology and carcinogenesis
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Gisiri, M., Joo, E., Penny, C., Horwitz, E., Makarushka, C., Vasudevan, L., & Schroeder, K. (2021). Burkitt Lymphoma Outcomes Following Implementation of Tanzania National Treatment Guidelines. In PEDIATRIC BLOOD & CANCER (Vol. 68, pp. S79–S80).
Gisiri, M., E. Joo, C. Penny, E. Horwitz, C. Makarushka, L. Vasudevan, and K. Schroeder. “Burkitt Lymphoma Outcomes Following Implementation of Tanzania National Treatment Guidelines.” In PEDIATRIC BLOOD & CANCER, 68:S79–80, 2021.
Gisiri M, Joo E, Penny C, Horwitz E, Makarushka C, Vasudevan L, et al. Burkitt Lymphoma Outcomes Following Implementation of Tanzania National Treatment Guidelines. In: PEDIATRIC BLOOD & CANCER. 2021. p. S79–80.
Gisiri, M., et al. “Burkitt Lymphoma Outcomes Following Implementation of Tanzania National Treatment Guidelines.” PEDIATRIC BLOOD & CANCER, vol. 68, 2021, pp. S79–80.
Gisiri M, Joo E, Penny C, Horwitz E, Makarushka C, Vasudevan L, Schroeder K. Burkitt Lymphoma Outcomes Following Implementation of Tanzania National Treatment Guidelines. PEDIATRIC BLOOD & CANCER. 2021. p. S79–S80.
Published In
PEDIATRIC BLOOD & CANCER
EISSN
1545-5017
ISSN
1545-5009
Publication Date
2021
Volume
68
Start / End Page
S79 / S80
Related Subject Headings
- Oncology & Carcinogenesis
- 3213 Paediatrics
- 3211 Oncology and carcinogenesis
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences